Calculated based on number of publications stored in Pure and citations from Scopus
19982023

Research activity per year

Network

Karl Münger

  • Harvard University
  • Tufts University
  • Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
  • Infectious Diseases Division
  • Division of Genetics
  • Department of Biomedical Engineering
  • Department of Medicine
  • Cardiovascular Division
  • The CBR Institute for Biomedical Research
  • Department of Medicine
  • Massachusetts General Hospital Cancer Center
  • Brigham and Women’s Hospital
  • University of Michigan, Ann Arbor

External person

Miranda Grace

  • Harvard University
  • Infectious Diseases Division
  • Department of Medicine
  • Cardiovascular Division
  • The CBR Institute for Biomedical Research
  • Brigham and Women’s Hospital

External person

Irene Georgakoudi

  • Tufts University
  • Harvard University
  • Wellman Center for Photomedicine
  • Department of Biomedical Engineering
  • Biomedical Engineering Department
  • Massachusetts General Hospital

External person

Wenliang Li

  • Harvard University
  • Department of Biological Chemistry and Molecular Pharmacology
  • Department of Biological Chemistry and Molecular Pharmacology

External person

Ed Harlow

  • Harvard University
  • Department of Biological Chemistry and Molecular Pharmacology
  • Department of Biological Chemistry and Molecular Pharmacology

External person

Edwin V. Sperr

  • AU/UGA Medical Partnership
  • Augusta University

External person

Dorre A. Grueneberg

  • Harvard University
  • Augusta Pharmaceuticals Inc.
  • Department of Biological Chemistry and Molecular Pharmacology
  • Department of Biological Chemistry and Molecular Pharmacology

External person

Myra M. Hurt

  • Florida State University
  • Department of Biological Sciences
  • Department of Biological Sciences
  • Department of Biomedical Sciences

External person

Kyungwon Huh

  • Harvard University
  • Louisiana State University Health Sciences Center
  • Infectious Diseases Division
  • Department of Biochemistry and Molecular Biology
  • The CBR Institute for Biomedical Research
  • Division of Genetics
  • Brigham and Women’s Hospital

External person

Antonios Papadakis

  • Tufts University
  • Heraklion University Hospital
  • Department of Biomedical Engineering
  • Radiology Department
  • Harvard University
  • Massachusetts General Hospital

External person

Janette R. Hill

  • University of Georgia
  • Medical College of Georgia
  • Augusta University

External person

Dina Teshager

  • AU/UGA Medical Partnership

External person

Jacqueline Sawyer

  • Harvard University
  • Department of Biological Chemistry and Molecular Pharmacology
  • Department of Biological Chemistry and Molecular Pharmacology

External person

Karin Hellner

  • Harvard University
  • Infectious Diseases Division
  • Department of Medicine
  • Brigham and Women’s Hospital

External person

Jonathan M. Levitt

  • Tufts University

External person

Michael L. Whitfield

  • University of North Carolina at Chapel Hill
  • Dartmouth College
  • Dept. of Biochemistry and Biophysics
  • Department of Genetics

External person

Joseph Pearlberg

  • Harvard University
  • Department of Biological Chemistry and Molecular Pharmacology

External person

Fenghua Tian

  • Chinese Society of Therapeutic Radiology and Oncology
  • Tufts University
  • Department of Biomedical Engineering

External person

James M. Pipas

  • Department of Biological Sciences
  • University of Pittsburgh

External person

Jamie C. Timmons

  • Dana-Farber Cancer Institute
  • Harvard University
  • Department of Medical Oncology
  • Cardiovascular Division
  • Brigham and Women’s Hospital

External person

Kim E. Creek

  • University of South Carolina
  • Dept. of Pathology and Microbiology

External person

James A. DeCaprio

  • Harvard University
  • Department of Medical Oncology
  • Department of Medical Oncology
  • Brigham and Women’s Hospital

External person

Erica L. Bauerlein

  • Dana-Farber Cancer Institute
  • Harvard University
  • Department of Medical Oncology
  • Cardiovascular Division
  • Brigham and Women’s Hospital

External person

Nicholas A. Christakis

  • Harvard University
  • Department of Health Care Policy

External person

Jasmine O. Patterson

  • AU/UGA Medical Partnership

External person

Claudia Mujat

  • Tufts University
  • Department of Biomedical Engineering

External person

Richard Possemato

  • Dana-Farber Cancer Institute
  • Harvard University
  • Department of Medical Oncology
  • Cardiovascular Division
  • Brigham and Women’s Hospital

External person

Rachel Franchi

  • Dana-Farber Cancer Institute
  • Harvard University
  • Simmons College
  • Midwestern University
  • Department of Chemistry
  • Department of Genetics, Harvard Medical School
  • Department of Cancer Biology, Dana-Farber Cancer Institute

External person

Ronke Olowojesiku

  • AU/UGA Medical Partnership

External person

Samantha A. Schoenl

  • AU/UGA Medical Partnership
  • Augusta University
  • Medical College of Georgia

External person

Frederick Boyce

  • Harvard University
  • Department of Neurology
  • Massachusetts General Hospital

External person

Jessica C. Mar

  • Harvard University
  • Center for Cancer Computational Biology (CCCB)

External person

Alyce Chen

  • Harvard University
  • Infectious Diseases Division

External person

Vadim Backman

  • Northwestern University
  • Department of Biomedical Engineering

External person

Renee Rubio

  • Harvard University
  • Center for Cancer Computational Biology (CCCB)

External person

Martin Hunter

  • Tufts University
  • Massachusetts Institute of Technology
  • George R. Harrison Spectroscopy Laboratory
  • Department of Biomedical Engineering

External person

Bryanna Moppins

  • AU/UGA Medical Partnership

External person

Natali Gulbahce

  • Northeastern University
  • Dana-Farber Cancer Institute
  • University of California at San Francisco
  • Department of Cellular and Molecular Pharmacology
  • Department of Cancer Biology, Dana-Farber Cancer Institute
  • Center for Complex Networks Research (CCNR) and Department of Physics

External person

Young L. Kim

  • Northwestern University
  • Department of Biomedical Engineering

External person

Dan McGee

  • Florida State University

External person

Calisha Hyacinth-Purcell

  • St. George’s University

External person

Maria Teresa Sáenz-Robles

  • Department of Biological Sciences
  • University of Pittsburgh

External person

Jane McPherson

  • University of Georgia

External person

Pascal Braun

  • Dana-Farber Cancer Institute
  • Harvard University
  • Department of Genetics, Harvard Medical School
  • Department of Cancer Biology, Dana-Farber Cancer Institute

External person

Albert László Barabási

  • Northeastern University
  • Dana-Farber Cancer Institute
  • Harvard University
  • Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
  • Department of Cancer Biology, Dana-Farber Cancer Institute
  • Center for Complex Networks Research (CCNR) and Department of Physics

External person

Sebastien Degot

  • Harvard University
  • Department of Biological Chemistry and Molecular Pharmacology

External person

Elliott Kieff

  • Harvard University
  • Infectious Diseases Division

External person

P. J. Fields

  • St. George's University

External person

Hiroyuki Hayakawa

  • Harvard University
  • The CBR Institute for Biomedical Research

External person

Katherine A. Eliassen

  • Florida State University
  • Department of Biological Sciences

External person

Yanhui Hu

  • Harvard University
  • Department of Biological Chemistry and Molecular Pharmacology

External person

Michael A. Calderwood

  • Dana-Farber Cancer Institute
  • Harvard University
  • Infectious Diseases Division
  • Department of Cancer Biology, Dana-Farber Cancer Institute

External person

Danielle Byrdsong

  • Dana-Farber Cancer Institute
  • Harvard University
  • Department of Genetics, Harvard Medical School
  • Department of Cancer Biology, Dana-Farber Cancer Institute

External person

Jarrod A. Marto

  • Dana-Farber Cancer Institute
  • Blais Proteomics Center and Department of Cancer Biology

External person

Marc Vidal

  • Dana-Farber Cancer Institute
  • Harvard University
  • Department of Genetics, Harvard Medical School
  • Department of Cancer Biology, Dana-Farber Cancer Institute

External person

John Quackenbush

  • Harvard University
  • Center for Cancer Computational Biology (CCCB)

External person

De Loris Wenzel Hesse

  • University of Georgia
  • AU/UGA Medical Partnership

External person

William F. Marzluff

  • University of North Carolina at Chapel Hill
  • Prog. in Molec. Biol. and Biotech.
  • Dept. of Biochemistry and Biophysics

External person

Deborah J. Shim

  • AU/UGA Medical Partnership

External person

Deok Sun Lee

  • Northeastern University
  • Inha University
  • Department of Natural Medical Sciences and Department of Physics
  • Center for Complex Networks Research (CCNR) and Department of Physics

External person

Joan E. Davies

  • Harvard University
  • Panomics, Inc.
  • Department of Biological Chemistry and Molecular Pharmacology

External person

Wilson Endege

  • Harvard University
  • Department of Biological Chemistry and Molecular Pharmacology

External person

Megha Padi

  • Harvard University
  • Center for Cancer Computational Biology (CCCB)

External person

Hank W. Bass

  • Florida State University
  • Department of Biological Science, Florida State University

External person

Maroun J. Beyrouthy

  • Florida State University
  • Dartmouth College
  • Department of Biomedical Sciences
  • Department of Biological Science, Florida State University
  • Department of Pharmacology and Toxicology

External person

Orit Rozenblatt-Rosen

  • Harvard University
  • Department of Medical Oncology
  • Department of Medical Oncology
  • Brigham and Women’s Hospital

External person

K. Masutomi

  • Dana Farber Cancer Institute
  • Dana-Farber Cancer Institute
  • National Cancer Center Japan
  • Department of Medical Oncology
  • Cancer Stem Cell Project

External person

Lian Xing Zheng

  • University of North Carolina at Chapel Hill
  • Dept. of Biochemistry and Biophysics

External person

Michael E. Cusick

  • Dana-Farber Cancer Institute
  • Harvard University
  • Department of Genetics, Harvard Medical School
  • Department of Cancer Biology, Dana-Farber Cancer Institute

External person

Balaji Santhanam

  • Dana-Farber Cancer Institute
  • Harvard University
  • Department of Genetics, Harvard Medical School
  • Department of Cancer Biology, Dana-Farber Cancer Institute

External person

Cherry Greiner

  • Tufts University
  • Department of Biomedical Engineering

External person

Dan Fitzpatrick

  • Department of Pathobiology
  • St. George's University Grenada

External person

Claudia S. Vega-Castillo

  • AU/UGA Medical Partnership

External person

Jonathan M. Levitt

  • Tufts University
  • Department of Biomedical Engineering
  • Biomedical Engineering Department

External person

W. C. Hahn

  • Dana-Farber Cancer Institute
  • Harvard University
  • Massachusetts Institute of Technology
  • Department of Medical Oncology
  • Department of Medical Oncology
  • Cardiovascular Division
  • Brigham and Women’s Hospital

External person

Joanna Xylas

  • Tufts University
  • Biomedical Engineering Department

External person

Frederick P. Roth

  • Dana-Farber Cancer Institute
  • Harvard University
  • University of Toronto
  • Department of Biological Chemistry and Molecular Pharmacology
  • Department of Cancer Biology, Dana-Farber Cancer Institute
  • Donnelly Centre for Cellular and Biomolecular Research
  • Mount Sinai Hospital of University of Toronto

External person

R. Hage

  • St. George's University
  • Department of Anatomy
  • Department of Anatomical Sciences
  • St. George's University

External person

Lucia Pirisi

  • University of South Carolina
  • Dept. of Pathology and Microbiology

External person

Karen E. Alexander

  • Florida State University
  • Department of Biomedical Sciences

External person

Naoya Wada

  • Dana-Farber Cancer Institute
  • Harvard University
  • Department of Medical Oncology
  • Cardiovascular Division
  • Brigham and Women’s Hospital

External person

Lee A. Stucenski

  • Tufts University
  • Department of Biomedical Engineering

External person

M. Tresa Chappell

  • AU/UGA Medical Partnership

External person

Daye Park

  • AU/UGA Medical Partnership

External person

L. Riley

  • St. George's University
  • School of Medicine

External person

Lynn M. Ramsey

  • AU/UGA Medical Partnership

External person

Bo Zhao

  • Harvard University
  • Infectious Diseases Division
  • Department of Radiation Oncology
  • Henry Ford Health System

External person

Jun Xian

  • Harvard University
  • Department of Biological Chemistry and Molecular Pharmacology

External person

Ellen House

  • AU/UGA Medical Partnership

External person

Amélie Dricot

  • Dana-Farber Cancer Institute
  • Harvard University
  • Department of Genetics, Harvard Medical School
  • Department of Cancer Biology, Dana-Farber Cancer Institute

External person

David E. Hill

  • Department of Genetics, Harvard Medical School
  • Harvard University
  • Dana-Farber Cancer Institute
  • Department of Cancer Biology, Dana-Farber Cancer Institute

External person

John Doench

  • Harvard University
  • Department of Biological Chemistry and Molecular Pharmacology

External person

Michael Owens

  • Harvard University
  • The CBR Institute for Biomedical Research

External person

Cathy Snapp

  • Augusta University

External person

Christine L. Nguyen

  • Harvard University
  • The CBR Institute for Biomedical Research

External person

Connie L. Xu

  • Department of Biological Sciences
  • University of Pittsburgh

External person

Han Yan

  • Dana-Farber Cancer Institute
  • Harvard University
  • Department of Genetics, Harvard Medical School
  • Department of Cancer Biology, Dana-Farber Cancer Institute

External person

A. Bahadoor-Yetman

  • St. George's University
  • Microbiology Department

External person

Douglas E. Norris

  • Department of Molecular Microbiology and Immunology
  • Johns Hopkins University

External person

Eric M. Sikorski

  • Florida State University

External person

Tomohiko Ohta

  • University of North Carolina at Chapel Hill
  • St. Marianna University School of Medicine
  • Department of Surgery

External person

V. Mapp-Alexander

  • St. George's University
  • Pathobiology Department

External person

Paul G. Cantalupo

  • Department of Biological Sciences
  • University of Pittsburgh

External person

Nicolas Simonis

  • Dana-Farber Cancer Institute
  • Harvard University
  • Université libre de Bruxelles
  • Department of Genetics, Harvard Medical School
  • Department of Cancer Biology, Dana-Farber Cancer Institute
  • Laboratoire de Bioinformatique des Génomes et des Réseaux

External person

Michael Feld

  • Massachusetts Institute of Technology
  • George R. Harrison Spectroscopy Laboratory

External person

Kirsten M. Edwards

  • Harvard University
  • The CBR Institute for Biomedical Research

External person

A. Gibbons

  • St. George's University
  • School of Medicine

External person

Ethan Jackson

  • Microsoft USA

External person

Jennifer Roecklein-Canfield

  • Dana-Farber Cancer Institute
  • Harvard University
  • Simmons College
  • Department of Chemistry
  • Department of Genetics, Harvard Medical School
  • Department of Cancer Biology, Dana-Farber Cancer Institute

External person

Sameer Puri

  • Tufts University
  • Biomedical Engineering Department

External person

Mary T. Bond

  • Medical College of Georgia
  • AU/UGA Medical Partnership

External person